Rosuvastatin Tablet, Film Coated
Product Images NDC 71335-2406

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71335-2406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence line graph comparing Rosuvastatin (labeled Rosuva) and placebo over a period of 5 years. The graph shows percentage cumulative incidence on the y-axis and years on the x-axis, indicating a lower incidence with Rosuvastatin versus placebo, supported by a hazard ratio (HR) of 0.56 with 95% confidence interval (0.46-0.69) and a p-value below 0.001. Number at risk for both groups is tabulated below the graph at various time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table comparing the number of events for various cardiovascular outcomes between Rosuvastatin 20 mg and placebo 20 mg groups in a clinical study. The table includes event rates, hazard ratios (HR) with 95% confidence intervals (CI), and p values for endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. A forest plot visualizes hazard ratios with confidence intervals for each endpoint.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box-and-whisker plot comparing the percent change from baseline in LDL-C across different doses (mg) of four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis lists doses for each drug, while the y-axis shows percent change from 0 to -75. Each drug group displays variability in LDL-C reduction at increasing doses.*
FDA Label Image

Label (Lbl713352406)

Label (Lbl713352406)
Label for Rosuvastatin Tablets, USP 20 mg film-coated oral tablets. The package contains 30 tablets. Labeler is Bryant Ranch Prepack, with manufacturing by ScieGen Pharmaceuticals, Inc. The label includes storage and warning instructions, a QR code for package insert and prescribing information, and the NDC code 71335-2406-1.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure of rosuvastatin calcium, showing its molecular arrangement including fluorophenyl, pyrimidine, sulfonamide, hydroxyl, and carboxylate groups with calcium ions indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.